OXA-181 carbapenemase carried on an IncX3 plasmid in high-risk Escherichia coli ST167 isolated from a traveler returning from Sub-Saharan Africa to Brazil

Diagn Microbiol Infect Dis. 2022 Jan;102(1):115570. doi: 10.1016/j.diagmicrobio.2021.115570. Epub 2021 Oct 8.

Abstract

This is the first detection and genomic analysis of an OXA-181-carbapenemase-producing E. coli in Brazil, from a traveler returning from Sub-Saharan Africa. The ST167 isolate carries blaOXA-181 inserted in an IncX3 plasmid. This report illustrates the potential role of travelers as silent vectors for dissemination of high-risk resistant clones.

Keywords: Carbapenemase-producing Escherichia coli; High-risk clone; OXA-181; Travel medicine.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Africa South of the Sahara
  • Anti-Bacterial Agents / pharmacology*
  • Brazil / epidemiology
  • Drug Resistance, Multiple, Bacterial / genetics*
  • Escherichia coli / genetics*
  • Escherichia coli Proteins / genetics*
  • Feces / microbiology
  • Genome, Bacterial
  • Humans
  • Male
  • Microbial Sensitivity Tests
  • Plasmids
  • beta-Lactamases / genetics*

Substances

  • Anti-Bacterial Agents
  • Escherichia coli Proteins
  • beta-Lactamases
  • beta-lactamase OXA-181, E coli